LTF ameliorates cartilage endplate degeneration by suppressing calcification, senescence and matrix degradation through the JAK2/STAT3 pathway

被引:2
|
作者
Li, Tao [1 ]
Liu, Yuchi [1 ]
Cao, Jian [1 ,2 ]
Pan, Chongzhi [1 ]
Ding, Rui [1 ]
Zhao, Jiangminghao [1 ]
Liu, Jiahao [1 ]
He, Dingwen [1 ,2 ,3 ]
Jia, Jingyu [1 ,2 ,3 ]
Cheng, Xigao [1 ,2 ,3 ]
机构
[1] Nanchang Univ, Affiliated Hosp 2, Dept Orthoped, 1 Minde Rd, Nanchang 330006, Jiangxi, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 2, Inst Orthoped Jiangxi Prov, Nanchang, Peoples R China
[3] Nanchang Univ, Inst Minimally Invas Orthoped, Nanchang, Peoples R China
基金
中国国家自然科学基金;
关键词
calcification; cartilage endplate degeneration; extracellular matrix degradation; JAK2/STAT3; pathway; lactotransferrin; senescence; DISC DEGENERATION; LACTOFERRIN; PAIN;
D O I
10.1111/jcmm.18267
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Intervertebral disc degeneration (IDD)-induced cervical and lumbar herniations are debilitating diseases. The function of intervertebral disc (IVD) mainly depends on the cartilage endplate (CEP), which provides support and waste removal. Therefore, IDD stems from the degeneration of CEP. Our study shows that the expression of lactotransferrin (LTF), an iron-binding protein, is significantly decreased in degenerated human and rat CEP tissues. In addition, we found that LTF knockdown promoted calcification, senescence, and extracellular matrix (ECM) degradation in human endplate chondrocytes. Furthermore, the in vivo experiment results confirmed that the JAK2/STAT3 pathway inhibitor AG490 significantly reversed these effects. In addition to investigating the role and mechanism of LTF in CEP degeneration, this study provides a theoretical basis and experimental evidence to improve IDD treatment.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] α-Ketoglutaric acid ameliorates intervertebral disk degeneration by blocking the IL-6/JAK2/STAT3 pathway
    Xu, Hao-Wei
    Fang, Xin-Yue
    Liu, Xiao-Wei
    Zhang, Shu-Bao
    Yi, Yu-Yang
    Chang, Sheng-Jie
    Chen, Hao
    Wang, Shan-Jin
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2023, 325 (04): : C1119 - C1130
  • [2] Inhibition of the breast cancer by PPARγ agonist pioglitazone through JAK2/STAT3 pathway
    Jiao, X. X.
    Lin, S. Y.
    Lian, S. X.
    Qiu, Y. R.
    Li, Z. H.
    Chen, Z. H.
    Lu, W. Q.
    Zhang, Y.
    Deng, L.
    Jiang, Y.
    Hu, G. H.
    NEOPLASMA, 2020, 67 (04) : 834 - 842
  • [3] New bitongling (NBTL) ameliorates rheumatoid arthritis in rats through inhibiting JAK2/STAT3 signaling pathway
    Li, Xiang
    Xie, Yu
    Kang, An
    Wang, Yue
    EUROPEAN JOURNAL OF HISTOCHEMISTRY, 2021, 65 (01): : 1 - 9
  • [4] YWHAG promotes the progression of lung adenocarcinoma through the JAK2/STAT3 pathway
    Zheng, Hongmei
    Tang, Yaoxiang
    Zang, Hongjing
    Luo, Jiadi
    Zhou, Hanqiong
    Zou, Ying
    Peng, Jinwu
    Fan, Songqing
    CANCER CELL INTERNATIONAL, 2025, 25 (01)
  • [5] Aβ-induced microglial cell activation is inhibited by baicalin through the JAK2/STAT3 signaling pathway
    Xiong, Jiaxiang
    Wang, Changzheng
    Chen, Hongyan
    Hu, Yazhuo
    Tian, Lei
    Pan, Jingkun
    Geng, Miao
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2014, 124 (08) : 609 - 619
  • [6] Botulinum toxin type A inhibits the formation of hypertrophic scar through the JAK2/STAT3 pathway
    Fan, Yan
    Guo, Xuesong
    Tian, Yu
    Li, Jie
    Xi, Hongwei
    BIOMOLECULES AND BIOMEDICINE, 2024, 25 (01): : 249 - 258
  • [7] Puerarin Ameliorates the Ferroptosis in Diabetic Liver Injure Through the JAK2/STAT3 Pathway Inhibition Based on Network Pharmacology and Experimental Validation
    Fan, Xiaoxu
    Liu, Shuangqiao
    Yu, Jing
    Hua, Jian
    Feng, Yingtong
    Wang, Zhen
    Shen, Yiwei
    Lan, Wei
    Wang, Jingxia
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2025, 19 : 737 - 757
  • [8] Lp-PLA2 silencing ameliorates inflammation and autophagy in nonalcoholic steatohepatitis through inhibiting the JAK2/STAT3 pathway
    Yao, Jinmei
    Zhao, Ying
    PEERJ, 2023, 11
  • [9] JAK2/STAT3 pathway as a therapeutic target in ovarian cancers
    Yoshikawa, Tomoyuki
    Miyamoto, Morikazu
    Aoyama, Tadashi
    Soyama, Hiroaki
    Goto, Tomoko
    Hirata, Junko
    Suzuki, Ayako
    Nagaoka, Isao
    Tsuda, Hitoshi
    Furuya, Kenichi
    Takano, Masashi
    ONCOLOGY LETTERS, 2018, 15 (04) : 5772 - 5780
  • [10] Cryptotanshinone alleviates immunosuppression in endometriosis by targeting MDSCs through JAK2/STAT3 pathway
    Xie, Linling
    Zhong, Yu
    Chen, Yi
    Wang, Yishu
    Xian, Peiyi
    Liu, Shanjia
    Xin, Xiaoyan
    Chen, Yanfen
    Guan, Yongge
    Li, Kunyin
    PHYTOMEDICINE, 2025, 136